These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26487555)

  • 21. Diffusion-weighted imaging of breast cancer: correlation of the apparent diffusion coefficient value with prognostic factors.
    Kim SH; Cha ES; Kim HS; Kang BJ; Choi JJ; Jung JH; Park YG; Suh YJ
    J Magn Reson Imaging; 2009 Sep; 30(3):615-20. PubMed ID: 19711411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of the Apparent Diffusion Coefficient in the Prediction of Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer.
    Bufi E; Belli P; Costantini M; Cipriani A; Di Matteo M; Bonatesta A; Franceschini G; Terribile D; Mulé A; Nardone L; Bonomo L
    Clin Breast Cancer; 2015 Oct; 15(5):370-80. PubMed ID: 25891905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastric cancer: The role of diffusion weighted imaging in the preoperative staging.
    Caivano R; Rabasco P; Lotumolo A; D' Antuono F; Zandolino A; Villonio A; Macarini L; Guglielmi G; Salvatore M; Cammarota A
    Cancer Invest; 2014 Jun; 32(5):184-90. PubMed ID: 24654696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of apparent diffusion coefficient calculation between two-point and multipoint B value analyses in prostate cancer and benign prostate tissue at 3 T: preliminary experience.
    Park SY; Kim CK; Park BK; Kwon GY
    AJR Am J Roentgenol; 2014 Sep; 203(3):W287-94. PubMed ID: 25148186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-4728-3p could act as a marker of HER2 status.
    Li H; Zhou X; Zhu J; Cheng W; Zhu W; Shu Y; Liu P
    Cancer Biomark; 2015; 15(6):807-14. PubMed ID: 26406406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response to chemotherapy in gastric adenocarcinoma with diffusion-weighted MRI and (18) F-FDG-PET/CT: correlation of apparent diffusion coefficient and partial volume corrected standardized uptake value with histological tumor regression grade.
    Giganti F; De Cobelli F; Canevari C; Orsenigo E; Gallivanone F; Esposito A; Castiglioni I; Ambrosi A; Albarello L; Mazza E; Gianolli L; Staudacher C; Del Maschio A
    J Magn Reson Imaging; 2014 Nov; 40(5):1147-57. PubMed ID: 24214734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical applications of diffusion-weighted-MRI in prostate cancer.
    Wibulpolprasert P; Phongkitkarun S; Chalermsanyakorn P
    J Med Assoc Thai; 2013 Aug; 96(8):967-75. PubMed ID: 23991605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
    Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
    Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topoisomerase IIalpha gene amplification in gastric carcinomas: correlation with the HER2 gene. An immunohistochemical, immunoblotting, and multicolor fluorescence in situ hybridization study.
    Kanta SY; Yamane T; Dobashi Y; Mitsui F; Kono K; Ooi A
    Hum Pathol; 2006 Oct; 37(10):1333-43. PubMed ID: 16949920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Value of MR diffusion-weighted imaging in diagnosis and outcome prediction for uterine cervical cancer].
    Wu B; Huang X; Peng W; Gu Y; Yang T; Mao J; Ke G; Wu X
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):115-9. PubMed ID: 24796459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II/III gastric cancer.
    Terashima M; Kitada K; Ochiai A; Ichikawa W; Kurahashi I; Sakuramoto S; Katai H; Sano T; Imamura H; Sasako M;
    Clin Cancer Res; 2012 Nov; 18(21):5992-6000. PubMed ID: 22977193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Grading astrocytic tumors by using apparent diffusion coefficient parameters: superiority of a one- versus two-parameter pilot method.
    Murakami R; Hirai T; Sugahara T; Fukuoka H; Toya R; Nishimura S; Kitajima M; Okuda T; Nakamura H; Oya N; Kuratsu J; Yamashita Y
    Radiology; 2009 Jun; 251(3):838-45. PubMed ID: 19318585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between apparent diffusion coefficients on diffusion-weighted MRI and standardized uptake value on FDG-PET/CT in pancreatic adenocarcinoma.
    Sakane M; Tatsumi M; Kim T; Hori M; Onishi H; Nakamoto A; Eguchi H; Nagano H; Wakasa K; Hatazawa J; Tomiyama N
    Acta Radiol; 2015 Sep; 56(9):1034-41. PubMed ID: 25267921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hybrid [¹⁸F]-FDG PET/MRI including non-Gaussian diffusion-weighted imaging (DWI): preliminary results in non-small cell lung cancer (NSCLC).
    Heusch P; Köhler J; Wittsack HJ; Heusner TA; Buchbender C; Poeppel TD; Nensa F; Wetter A; Gauler T; Hartung V; Lanzman RS
    Eur J Radiol; 2013 Nov; 82(11):2055-60. PubMed ID: 23830904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of HER2 gene amplification assessed by fluorescence in situ hybridization and HER2 protein expression assessed by immunohistochemistry in gastric cancer.
    Yano T; Doi T; Ohtsu A; Boku N; Hashizume K; Nakanishi M; Ochiai A
    Oncol Rep; 2006 Jan; 15(1):65-71. PubMed ID: 16328035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contrast-enhanced dynamic and diffusion-weighted MR imaging at 3.0T to assess aggressiveness of bladder cancer.
    Zhou G; Chen X; Zhang J; Zhu J; Zong G; Wang Z
    Eur J Radiol; 2014 Nov; 83(11):2013-8. PubMed ID: 25213829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ideal number of biopsy tumor fragments for predicting HER2 status in gastric carcinoma resection specimens.
    Ahn S; Ahn S; Van Vrancken M; Lee M; Ha SY; Lee H; Min BH; Lee JH; Kim JJ; Choi S; Jung SH; Choi MG; Lee JH; Sohn TS; Bae JM; Kim S; Kim KM
    Oncotarget; 2015 Nov; 6(35):38372-80. PubMed ID: 26460823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathologic characteristics of patients with stage III/IV (M(0)) advanced gastric cancer, according to HER2 status assessed by immunohistochemistry and fluorescence in situ hybridization.
    Im SA; Kim JW; Kim JS; Kim MA; Jordan B; Pickl M; Han SW; Oh DY; Lee HJ; Kim TY; Kim WH; Yang HK; Bang YJ
    Diagn Mol Pathol; 2011 Jun; 20(2):94-100. PubMed ID: 21532492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results.
    Lambrecht M; Vandecaveye V; De Keyzer F; Roels S; Penninckx F; Van Cutsem E; Filip C; Haustermans K
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):863-70. PubMed ID: 21398048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A study of HER2 gene amplification and protein expression in gastric cancer.
    Yan B; Yau EX; Bte Omar SS; Ong CW; Pang B; Yeoh KG; Salto-Tellez M
    J Clin Pathol; 2010 Sep; 63(9):839-42. PubMed ID: 20696687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.